SCHEMBL24313539

SCHEMBL24313539

COc1ccc(CNc2ncnc3c2c(Br)cn3[C@@H]2O[C@H](COC3CCC3)[C@H]3OC(C)(C)O[C@H]32)c(OC)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 9/20 0.36
▸ CYP3A4 P08684 9/20 0.36
▸ CYP2C19 P33261 9/20 0.36
▸ ADORA3 P0DMS8 6/20 0.36
▸ ALDH1A1 P00352 8/20 0.36
▸ TSHR P16473 7/20 0.36
▸ CYP2D6 P10635 7/20 0.36
▸ CLK4 Q9HAZ1 6/20 0.36
▸ USP2 O75604 4/20 0.36
▸ CYP2C9 P11712 5/20 0.35
▸ MAPK1 P28482 5/20 0.35
▸ LMNA P02545 4/20 0.35
▸ HSD17B10 Q99714 4/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ ADORA2A P29274 1/20 0.35
▸ ADORA1 P30542 1/20 0.35
▸ HIF1A Q16665 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23273892 0.88 ADORA3 (0.44) CYP1A2CYP3A4CYP2C19ADORA3ALDH1A1
SCHEMBL29610857 0.83 ADORA3 (0.43) CYP1A2CYP3A4CYP2C19ADORA3ALDH1A1
SCHEMBL29611653 0.83 ADORA3 (0.43) CYP1A2CYP3A4CYP2C19ADORA3ALDH1A1
SCHEMBL24313864 0.83 ADORA3 (0.43) CYP1A2CYP3A4CYP2C19ADORA3ALDH1A1
SCHEMBL24313565 0.83 ADORA3 (0.43) CYP1A2CYP3A4CYP2C19ADORA3ALDH1A1
SCHEMBL23312996 0.81 ADORA3 (0.42) ADORA3ADORA2AADORA1
SCHEMBL24314227 0.80 ADORA3 (0.44) CYP1A2CYP3A4CYP2C19ADORA3ALDH1A1
SCHEMBL24313535 0.79 ADORA3 (0.40) ADORA3
SCHEMBL29610818 0.79 ADORA3 (0.40) ADORA3
SCHEMBL29772282 0.79 RXFP1 (0.37) CYP1A2CYP3A4CYP2C19ADORA3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081739-A1 METTL3 MODULATORS ACCENT THERAPEUTICS, INC. (US) 2022-04-21 — — WO disclosed
Send feedback